Evidence-based psychological treatments: An update and a way forward

Annual Review of Clinical Psychology

Volumn 9, Issue , 2013, Pages 1-27

  Barlow, David H ^a   Bullis, Jacqueline R ^a   Comer, Jonathan S ^a   Ametaj, Amantia A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

dissemination; methodology; psychological treatments; temperament

Indexed keywords

OXYTOCIN; PLACEBO;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CLINICAL PRACTICE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; EVIDENCE BASED PRACTICE; HEALTH CARE DELIVERY; HUMAN; INFORMATION DISSEMINATION; INSOMNIA; MENTAL DISEASE; PANIC; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; STRESS INCONTINENCE; SYSTEMATIC DESENSITIZATION; TEMPERAMENT;

EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MENTAL DISORDERS; PSYCHOLOGY, CLINICAL; PSYCHOTHERAPY;

EID: 84875904022     PISSN: 15485943     EISSN: 15485951     Source Type: Book Series    
DOI: 10.1146/annurev-clinpsy-050212-185629     Document Type: Review

References (139)

1. Addington J, Piskulic D, Marshall D. 2010. Psychological treatments for schizophrenia. Curr. Dir. Psychol. Sci. 19:260-633
2. Arkowitz H, Westra HA,MillerWR, Rollnick S. 2008. Motivational Interviewing in the Treatment of Psychological Problems. New York: Guilford
3. Arkowitz H, Westra HA,MillerWR, Rollnick S. 2008. Motivational Interviewing in the Treatment of Psychological Problems. New York: Guilford
4. Barlow DH. 1988. Anxiety and Its Disorders: TheNature and Treatment of Anxiety and Panic.NewYork:Guilford Barlow DH. 1991. Disorders of emotion. Psychol. Inq. 2:58-711
5. Barlow DH. 1996. Healthcare policy, psychotherapy research, and the future of psychotherapy. Am. Psychol. 51:1050-588
6. Barlow DH. 2000. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am. Psychol. 55:1247-633
7. Barlow DH. 2002. Anxiety and Its Disorders: TheNature and Treatment of Anxiety and Panic.New York:Guilford. 2nd ed.
8. Barlow DH. 2004. Psychological treatments. Am. Psychol. 59:869-788
9. Barlow DH. 2006. Psychotherapy and psychological treatments: The future. Clin. Psychol. Sci. Pract. 13:216-200
10. Barlow DH. 2008. Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual. New York: Guilford. 4th ed.
11. Barlow DH. 2010. Negative effects from psychological treatments: A perspective. Am. Psychol. 65:13-200
12. Barlow DH. 2011a. A prolegomenon to clinical psychology: Two 40-year odysseys. See Barlow 2011b, pp. 3-200
13. Barlow DH. 2011b. The Oxford Handbook of Clinical Psychology. New York: Oxford Univ. Presss
14. Barlow DH, Carl Jr. 2011. The future of clinical psychology: Promises, perspectives, and predictions. See Barlow 2011b, pp. 891-912
15. Barlow DH, Craske MG. 2007. Mastery of Your Anxiety and Panic: Workbook. New York: Oxford Univ. Press. 4th ed.
16. Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, et al. 2011. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide. New York: Oxford Univ. Presss
17. Barlow DH, Gorman JM, Shear MK,Woods SW. 2000. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 283:2529-366
18. Barlow DH,NockMK. 2009. Why can't we be more idiographic in our research? Perspect. Psychol. Sci. 4:19-211
19. Barlow DH, Nock MK, Hersen M. 2009. Single Case Experimental Designs: Strategies for Studying Behavior Change. Boston, MA: Pearson. 3rd ed.
20. Beidas RS, Edmunds J, Marcus S, Kendall PC. 2012. An RCT of training and consultation as implementation strategies for an empirically supported treatment. Psychiatr. Serv. 63:660-655
21. Beidas RS, Kendall PC. 2010. Training therapists in evidence-based practice: A critical review of studies from a systems-contextual perspective. Clin. Psychol. Sci. Pract. 17:1-300
22. Beidas RS,Mehta T, Atkins M, Solomon B,Merz J. 2012. Dissemination and implementation science: Research models and methods. In The Oxford Handbook of Research Strategies for Clinical Psychology, ed. JS Comer, PC Kendall. New York: Oxford Univ. Press. In Presss
23. Bergin AE, Strupp HH. 1972. Changing Frontiers in the Science of Psychotherapy. Chicago, IL: Aldine.
24. Blackledge JT, Hayes SC. 2001. Emotion regulation in acceptance and commitment therapy. J. Clin. Psychol. 57:243-555
25. Bouton ME, Mineka S, Barlow DH. 2001. A modern learning theory perspective on the etiology of panic disorder. Psychol. Rev. 108:4-322
26. BrownTA. 2007. Temporal course and structural relationships among dimensions of temperament andDSMIV anxiety and mood disorder constructs. J. Abnorm. Psychol. 116:313-288
27. Brown TA, Antony MM, Barlow DH. 1995. Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. J. Clin. Psychol. 63:408-188
28. Brown TA, Barlow DH. 2009. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: Implications for assessment and treatment. Psychol. Assess. 21:256-711
29. Brown TA, Chorpita BF, Barlow DH. 1998. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J. Abnorm. Psychol. 107:179-922
30. Bruns EJ, Hoagwood KE. 2008. State implementation of evidence-based practice for youths, part I: Responses to the state of the evidence. J. Am. Acad. Child Adolesc. Psychiatry 47:369-733
31. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, et al. 1998. Behavioral versus drug treatment for urge urinary incontinence in older women: A randomized controlled trial. JAMA 280:1995-20000
32. Campbell-Sills L, Barlow DH. 2007. Incorporating emotion regulation into conceptualizations and treatments of anxiety and mood disorders. In Handbook of Emotion Regulation, ed. JJ Gross, pp. 542-59. New York: Guilfordd
33. Campbell-Sills L, Barlow DH, Brown TA, Hofmann SG. 2006. Effects of suppression and acceptance on emotional responses of individuals with anxiety and mood disorders. Behav. Res. Ther. 44:1251-633
34. Campbell-Sills L, Ellard KK, Barlow DH. 2012. Emotion regulation in anxiety disorders. In Handbook of Emotion Regulation, ed. JJ Gross. New York: Guilford. 2nd ed. In Presss
35. Chawla N, Ostafin B. 2007. Experiential avoidance as a functional dimensional approach to psychopathology: An empirical review. J. Clin. Psychol. 63:871-900
36. Chorpita BF,Miranda J, Bernstein A. 2011. Creating public health policy: The dissemination of evidence-based psychological interventions. See Barlow 2011b, pp. 210-244
37. Chorpita BF,Weisz Jr. 2009. MATCH-ADTC: Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems. Satellite Beach, FL: PracticeWisee
38. Clark DM. 2012. The English Improving Access to Psychological Treatments (IAPT) program: History and progress. See McHugh & Barlow 2012, pp. 61-777
39. Clark LA. 2005. Temperament as a unifying basis for personality and psychopathology. J. Abnorm. Psychol. 114:505-211
40. Clark LA, Watson D, Mineka S. 1994. Temperament, personality, and the mood and anxiety disorders. J. Abnorm. Psychol. 103:103-166
41. Comer JS, Mojtabai R, Olfson M. 2011. National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am. J. Psychiatry 168:1057-655
42. Craske MG, Barlow DH. 2008. Panic disorder and agoraphobia. In Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual, ed. DH Barlow, pp. 1-64. New York: Guilford. 4th ed.
43. Craske MG, Kircanski K, ZelikowskyM,Mystkowski J, Chowdhury N, Baker A. 2008. Optimizing inhibitory learning during exposure therapy. Behav. Res. Ther. 46:5-277
44. Crits-Christoph P, Siqueland L,Chittams J, Barber JP, Beck AT, et al. 1998. Training in cognitive, supportiveexpressive, and drug counseling therapies for cocaine dependence. J. Consult. Clin. Psychol. 66:484-922
45. Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. 2012. The efficacy of non-directive supportive therapy for adult depression: A meta-analysis. Clin. Psychol. Rev. 32:280-911
46. Daleiden EL, Chorpita BF, Donkervoet C, Arensdorf AM, Brogan M. 2006. Getting better at getting them better: Health outcomes and evidence-based practice within a system of care. J. Am. Acad. Child Adolesc. Psychiatry 45:749-566
47. Donta ST, Clauw DJ, Engel CC, Guarino P, Peduzzi P, et al. 2003. Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illness: A randomized controlled trial. JAMA 289:1396-4044
48. Driessen E, Cuijpers P, Hollon SD, Decker JJ. 2010. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. J. Consult. Clin. Psychol. 78:668-800
49. Eack SM,Hogarty GE, Cho RY, Prasad KM, Greenwald DP, et al. 2010. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: Results from a 2-year randomized controlled trial. Arch. Gen. Psychiatry 67:674-822
50. Ellard KK, FairholmeCP, Boisseau CL, Farchione TJ, BarlowDH. 2010. Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders: Protocol development and initial outcome data. Cogn. Behav. Pract. 17:88-1011
51. Ellis AR, Konrad TR, Thomas KC, Morrissey JP. 2009. County-level estimates of mental health professional supply in the United States. Psychiatr. Serv. 60:1315-222
52. Ennett ST, Tobler NS, Ringwalt CL, Flewelling RL 1994. How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations. Am. J. Public Health 84:1394-4011
53. Eysenck HJ. 1952. The effects of psychotherapy: An evaluation. J. Consult. Psychol. 16:319-277
54. Eysenck HJ. 1965. The effects of psychotherapy. Int. J. Psychiatry 1:97-1788
55. Fairburn CG, Cooper Z, DollHA, O'ConnorME, Bohn K, et al. 2009. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: A two-site trial with 60-week follow-up. Am. J. Psychiatry 166:311-199
56. Farchione TJ, Fairholme CF, Ellard KK, Boisseau CL, Thompson-Hollands J, et al. 2012. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: A randomized controlled trial. Behav. Ther. 43:666-788
57. Gallo KP, Barlow DH. 2012. Factors involved in clinician adoption and nonadoption of evidence-based interventions in mental health. Clin. Psychol. Sci. Pract. 19:93-1066
58. Gawande A. 2007. Better: A Surgeon's Notes on Performance. New York: Metropolitan Bookss
59. Gleacher AA, Nadeem E, Moy AJ, Whited AL, Albano AM, et al. 2011. Statewide CBT training for clinicians and supervisors treating youth: The New York State Evidence Based Treatment Dissemination Center. J. Emot. Behav. Disord. 19:182-922
60. Glisson C, Schoenwald SK, Kelleher K, Landsverk J, Hoagwood KE, et al. 2008. Therapist turnover and new program sustainability inmental health clinics as a function of organizational culture, climate, and service structure. Adm. Policy Ment. Health 35:124-333
61. Goode PS, Burgio KL, Locher JL, Roth DL, Umlauf MG, et al. 2003. Effects of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: A randomized controlled trial. JAMA 290:345-522
62. Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT. 2012. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch. Gen. Psychiatry 69:121-277
63. Griffith JW, Zinbarg RE, Craske MG,Mineka S, Rose RD, et al. 2010. Neuroticism as a common dimension in the internalizing disorders. Psychol. Med. 40:1125-366
64. Gross JJ. 1998. Antecedent- and response-focused emotion regulation: Divergent consequences for experience, expression, and physiology. J. Personal. Soc. Psychol. 74:224-377
65. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, et al. 2008. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol. Psychiatry 63:544-499
66. Harmer CJ, Goodwin GM, Cowen PJ. 2009. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br. J. Psychiatry 195:102-88
67. Harvey AG, Murray G, Chandler RA, Soehner A. 2010. Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms. Clin. Psychol. Rev. 3:225-355
68. Heinrichs M, von Dawans B, Domes G. 2009. Oxytocin, vasopressin, and human social behavior. Front. Neuroendocrinol. 30:548-577
69. Hersen M, Barlow DH. 1976. Single Case Experimental Designs: Strategies for Studying Behavior Change. New York: Pergamonn
70. Hofmann SG. 2007. Enhancing exposure-based therapy from a translational research perspective. Behav. Res. Ther. 45:1987-20011
71. Hofmann SG, Smits JA, Asnaani A, Gutner CA, Otto MW. 2011. Cognitive enhancers for anxiety disorders. Behav. Res. Ther. 99:275-844
72. Hollon SD. 2011. Cognitive and behavioral therapy in the treatment and prevention of depression. Depress. Anxiety 28:263-666
73. Horowitz M, Wilner N, Alvarez W. 1979. Impact of Event Scale: A measure of subjective stress. Psychosom. Med. 41:209-188
74. Huppert JD, BufkaLF, BarlowDH,Gorman JM, WoodsSW,ShearMK.2001. Therapists, therapist variables, and cognitive-behavioral therapy outcome in amulti-center trial for panic disorder. J. Consult. Clin. Psychol. 69:747-555
75. Huppert JD, Franklin ME, Foa EB, Simpson HB, Barlow DH. 2007. The relative contribution of therapists and technique: A reassessment using randomized trials of CBT for anxiety disorders. Presented at Annu. Meet. Soc. Psychother. Res., 38th, Madison, WII
76. Huppert JD, Schultz LT, Foa EB, Barlow DH, Davidson JR, et al. 2004. Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. Am. J. Psychiatry 161:1485-877
77. Kazdin AE. 2011. Evidence-based treatments research: Advances, limitations, and next steps. Am. Psychol. 66:685-988
78. Kazdin AE, Blaśe SL. 2011. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect. Psychol. Sci. 6:21-377
79. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, et al. 2000. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342:1462-700
80. Kernberg O. 1973. Summary and conclusions of psychotherapy and psychoanalysis. Final report of the Menninger Foundation's PsychotherapyResearchProject.Critical evaluations.Author's reply. Int. J. Psychiatry 11:95-1033
81. Labuschagne I, Phan KL,Wood A, Angstadt M, Chua P, et al. 2012. Medial frontal hyperactivity to sad faces in generalized social anxiety disorder andmodulation by oxytocin. Int. J. Neuropsychopharmacol. 15:883-966
82. LambertA. 2008. NewTreatment Options forCircadian Rhythm Sleep Disorders. Bethesda,MD: Clinical Compass. http://www.neurosciencecme.com/email/2008/ 100708-ckc.htm
83. Landes SJ,LinehanMM.2012. Dissemination and implementation of dialectical behavior therapy: An intensive training model. See McHugh & Barlow 2012, pp. 187-208
84. Leykin Y, DeRubeis RJ. 2009. Allegiance in psychotherapy outcome: Separating association from bias. Clin. Psychol. Sci. Pract. 16:54-655
85. Litz BT, Salters-Pedneault K, Steenkamp MM, Hermos JA, Bryant RA, et al. 2012. A randomized placebocontrolled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J. Psychiatr. Res. 71:962-688
86. Lochman JE, Boxmeyer C, Powell N, Qu L,Wells K, Windle M. 2009. Dissemination of the Coping Power program: Importance of intensity of counselor training. J. Consult. Clin. Psychol. 77:397-4099
87. Lyon AR, Frazier SL, MehtaT, AtkinsMS, Weisbach J. 2011. Easier said than done: Intervention sustainability in an urban after-school program. Adm. Policy Ment. Health 38:504-177
88. Marcus SC, Olfson M. 2010. National trends in the treatment for depression from 1998 to 2007. Arch. Gen. Psychiatry 67:1265-733
89. Mayou RA, Ehlers A, Hobbs M. 2000. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial. Br. J. Psychiatry 176:589-922
90. McCullough JP. 2002. What questions are we trying to answer with our psychotherapy research? Clin. Psychol. Sci. Pract. 9:447-522
91. McHugh RK, Barlow DH. 2010. The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. Am. Psychol. 65:73-844
92. McHugh RK, Barlow DH. 2012. Dissemination and Implementation of Evidence-based Psychological Interventions. New York: Oxford Univ. Presss
93. McHugh RK,Whitton SW, Peckham AD, Welge JA, Otto MW. 2012. Patient preference for psychological vs. pharmacological treatment of psychiatric disorders: A meta-analytic review. J. Clin. Psychol. In Presss
94. McLaughlin KA,Nolen-Hoeksema S. 2011. Rumination as a transdiagnostic factor in depression and anxiety. Behav. Res. Ther. 49:186-933
95. Mitchell MD, Gehrman P, Perlis M, Umscheid CA. 2012. Comparative effectiveness of cognitive behavioral therapy for insomnia: A systematic review. BMC Fam. Pract. 13:400
96. Moher D, Schulz KF, Altman D. 2001. The CONSORT statement: Revised recommendation for improving the quality of reports of parallel-group randomized trials. JAMA 285:1987-911
97. Monfils MH, Cowansage KK, Klann E, LeDoux JE. 2009. Extinction- reconsolidation boundaries: key to persistent attenuation of fear memories. Science 324:951-555
98. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, et al. 2006. Practice parameters for the psychological and behavioral treatment of insomnia: An update. An American Academy of Sleep Medicine report. Sleep 29:1415-199
99. MorinCM, ColecchiC, Stone J, Sood R, BrinkD. 1999. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial. JAMA 281:991-999
100. Morin CM, Vallieres A, Guay B, Ivers H, Savard J, et al. 2009. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA 301:2005-155
101. Nathan PE, Gorman JM. 2007. Treatments That Work. New York: Oxford Univ. Press. 3rd ed.
102. NewmanMG,PrzeworskiA, Fisher AJ, Borkovec TD. 2010. Diagnostic comorbidity in adults with generalized anxiety disorder: Impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses. Behav. Ther. 41:59-722
103. Nock MK. 2007. Conceptual and design essentials for evaluating mechanisms of change. Alcohol. Clin. Exp. Res. 31:4-12s
104. Norton PJ. 2008. An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder. Behav. Ther. 39:242-500
105. Olfson M, Marcus SC. 2009. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66:848-566
106. Olfson M, Marcus SC, Corey-Lisle P, Tuomari AV, Hines P, L'Italien GJ. 2006. Hyperlipidemia following treatment with antipsychotic medications. Am. J. Psychiatry 163:1821-255
107. OttoMW,Tolin DF, Simon NM, Pearlson GD, Basden S, et al. 2010. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol. Psychiatry 67:365-700
108. Paul GL. 1967. Strategy of outcome research in psychotherapy. J. Consult. Psychol. 31:109-188
109. PfammatterM, Junghan UM, Brenner HD. 2006. Efficacy of psychological therapy in schizophrenia: Conclusions from meta-analyses. Schizophr. Bull. 32(Suppl. 1):S64-800
110. Piacentini J,Woods DW, Scahill L, Wilhelm S, Peterson AL, et al. 2010. Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA 303:1929-377
111. Powers E, Witmer H. 1951. An Experiment in the Prevention of Delinquency: The Cambridge-Somerville Youth Study. New York: Columbia Univ. Presss
112. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P,Graap K, et al. 2004. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 61:1136-444
113. Rogers EM. 2003. Diffusion of Innovations. New York: Free Press. 5th ed.
114. Rosellini AJ, Brown TA. 2011. The NEO Five-Factor Inventory: Latent structure and relationships with dimensions of anxiety and depressive disorders in a large clinical sample. Assessment 18:27-388
115. Rosenberg RP. 2006. Sleep maintenance insomnia: Strengths and weaknesses of current pharmacologic therapies. Ann. Clin. Psychiatry 18:49-566
116. Roy-Byrne P,CraskeMG, Sullivan G, Rose RD, EdlundMJ, et al. 2010. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: A randomized controlled trial. JAMA 303:1921-288
117. Ruzek JI, Karlin BE,Zeiss A. 2012. Implementation of evidence-based psychological treatments in theVeterans Health Administration. See McHugh & Barlow 2012, pp. 78-988
118. Schnurr PP, Friedman MJ, Engel CC, Foa EB, Shea MT, et al. 2007. Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA 297:820-300
119. Schoenwald SK. 2012. The transport and diffusion of multisystemic therapy. See McHugh & Barlow 2012, pp. 227-466
120. Schoenwald SK, McHugh RK, Barlow DH. 2012. The science of dissemination and implementation. See McHugh & Barlow 2012, pp. 16-422
121. Shear MK, Houck P, Greeno C, Masters S. 2001. Emotion-focused psychotherapy for patients with panic disorder. Am. J. Psychiatry 158:1993-988
122. Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. 2005. We don't train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J. Consult. Clin. Psychol. 73:106-155
123. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B,Havik OE, et al 2006. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: A randomized controlled trial.JAMA295:2851-588
124. Spring B, Neville K. 2011. Evidence-based practice in clinical psychology. See Barlow 2011b, pp. 128-499
125. Stangier U, Schramm E,Heidenreich T, ClarkDM. 2011. Cognitive therapy versus interpersonal psychotherapy in social anxiety disorder. Arch. Gen. Psychiatry 68:692-7000
126. Strupp HH. 1964. The outcome problem in psychotherapy: A rejoinder. Psychother. Res. Pract. 1:1011
127. Tarrier N. 2008. Schizophrenia and other psychotic disorders. In Clinical Handbook of Psychological Disorders: A Step-By-Step Treatment Manual, ed. DH Barlow, pp. 463-91. New York: Guilford. 4th ed.
128. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, et al. 2003. Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial. JAMA 290:2015-222
129. Walker DL, Ressler KJ, Lu KT, Davis M. 2002. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J. Neurosci. 22:2343-511
130. Wampold BE. 2001. The Great Psychotherapy Debate: Models, Methods, and Findings. Hillsdale, NJ: Erlbaumm
131. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. 2005b. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:603-133
132. Wang PS, LaneM, OlfsonM, Pincus HA, Wells KB, Kessler RC. 2005a. Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:629-400
133. Weisz JR, Chorpita BF, Palinkas LA, Schoenwald SK, Miranda J, et al. 2012. Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: A randomized effectiveness trial. Arch. Gen. Psychiatry 69:274-822
134. Weisz JR, Gray JS. 2008. Evidenced-based psychotherapy for children and adolescents: Data from the present and a model for the future. Child Adolesc. Ment. Health 13:54-655
135. Weisz JR, Kazdin AE. 2010. Evidence-Based Psychotherapies for Children and Adolescents. New York: Guilford. 2nd ed.
136. Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH. 2010. Conceptual background, development, and preliminary data from the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders. Depress. Anxiety 27:882-900
137. Wilhelm S, BuhlmannU,Tolin DF,Meunier SA, Pearlson GD, et al. 2008. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am. J. Psychiatry 165:335-411
138. Witt DM, Winslow JT, Insel TR. 1992. Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacol. Biochem. Behav. 43:855-611
139. Xue YX, Luo YX, Wu P, Shi HS, Xue LF, et al. 2012. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science 336:241-455